Mr Ravi Mehrotra has been the Executive Chairman and Executive Director of RHT Health Trust Manager Pte. Ltd. (“RHT TM” or the “Trustee-Manager”) since 7 September 2012.
Mr Mehrotra has experience spanning over 30 years in the financial services sector both within India and internationally. He has with him, extensive experience in funds management, particularly in the areas of investment, corporate banking and equities. Prior to his appointment at RHT TM, he was the Managing Director and Global Head of Retail & Intermediary Channels at PineBridge Investments (previously AIG Investments) as well as Global Head of Retail & Intermediary Channels at AIG Investments. As Managing Director and Regional Head, he was responsible for overseeing asset management companies in China, India, the Philippines and Taiwan. In addition, he was previously the President and Chief Investment Officer (Equities) at Franklin Templeton Asset Management (India) as well as the Senior Vice President and Chief Investment Officer at Kothari Pioneer Asset Management. At the Bank of America in India, Mr Mehrotra was the Vice President in the Investment Banking and Treasury Group.
Mr Mehrotra graduated from the University of Mumbai with a Bachelor of Commerce. He also received a Post Graduate Diploma in Business Management from the Xavier Labour Relations Institute of Jamshedpur in India.
Mr Gurpreet Dhillon is the Chief Executive Officer and Executive Director of RHT TM where he oversees all key operations and business development plans of RHT. Mr Dhillon currently serves as a Director on the Board of Fortis Global Healthcare Infrastructure Pte. Ltd. and RHT Health Trust Services Pte. Ltd., both of which are wholly-owned subsidiaries of RHT.
Mr Dhillon is experienced in the fields of asset management and investments. He had played key advisory roles in real estate acquisitions across India and the United Kingdom during his career with a leading India financial services company, before he joined RHT TM in 2011. Mr Dhillon joined the Trustee-Manager as an Executive Director, before becoming the Chief Operating Officer in January 2013 and subsequently being appointed as the Chief Executive Officer.
Mr Dhillon graduated from the University of Essex with a Bachelor of Laws degree.
Mr Pawanpreet Singh has been the Chief Financial Officer (“CFO”) of RHT TM since 2011. He was also appointed as an Executive Director in January 2013, Mr Pawanpreet Singh has more than 25 years of experience in accounting and finance.
Prior to his appointment as CFO of RHT TM, Mr Singh spent most his career working in the healthcare sector in India. Between 2005 and 2011, Mr Singh held the position of Corporate Controller of Finance in Fortis Healthcare Limited (“FHL”), where he played a key role in its Initial Public Offering (“IPO”), rights and issuance of convertible bonds. He was also the CFO of Super Religare Laboratories Limited where he played an active role in its business development plans.
Mr Singh holds a Bachelor of Commerce (Honours) degree from Punjab University, Chandigarh. He is currently a member of the Institute of Chartered Accountants of India as well as the Institute of Costs & Works Accountants of India.
Dr Yogendra Nath Mathur joined the Board of the Trustee-Manager as Lead Independent Director on 7 September 2012.
Prior to his appointment, Dr Mathur spent a large part of his career with the United Nations Children’s Fund (“UNICEF”), where he held key positions. He was a member of the Country Management Team of UNICEF, which is the management team that oversees and guides the work that UNICEF carries out in India. Dr Mathur also sat on the Central Review Board of UNICEF, which oversees the recruitment of professionals in the organisation. During his time at UNICEF, Dr Mathur was actively involved in social development and welfare initiatives, particularly for women and children in Gujarat and the establishment of an immunisation programme and establishment of a disease surveillance system in Madhya Pradesh. Before joining UNICEF in 1989, Dr Mathur was employed by the Indian Council of Medical Research, New Delhi, India
Dr Mathur holds a Bachelor of Medicine and a Bachelor of Surgery from Nagpur University. In addition, he received a Doctorate of Medicine (Preventive and Social Medicine) from the All-India Institute of Medical Sciences, New Delhi. Dr Mathur is currently the Secretary of the Radha Soami Satsang Beas Society.
Mr Peter Rowe sits on the Board of the TrusteeManager and is also the Chairman of the Audit and Risk Management Committee.
Mr Rowe brings with him 40 years of experience in the financial services industry, particularly in the areas of funds management and compliance. He is currently a consultant at Herbert Smith Freehills where he was previously made Partner and was also appointed Head of the Financial Services Group. Apart from the Board of RHT TM, Mr Rowe sits the Board of other real estate management related companies in Australia, including his appointments as Chairman of the Managed Investments Scheme Compliance Committee within AMP Capital Investors Limited, as well as Chairman of UBS Grocon Real Estate Investment Management Pty Ltd.
Mr Rowe received a Diploma in Law from the Solicitors Admission Board of New South Wales, Australia.
Mr Eng Meng Leong is an Independent Director and serves on the Board of RHT TM as Chairman of the Remuneration Committee. Mr Eng brings with him expertise, spanning over 25 years, in the fields of taxation in Singapore and internationally. Mr Eng is also on the Board of Croesus Retail Asset Management Pte. Ltd., Trustee-Manager of another listed business trust in Singapore.
Prior to his appointment with RHT TM in 2013, Mr Eng was the Director of Tax Services and Head of Financial Services in KPMG Tax Services Pte. Ltd. (“KPMG”). During his stint with KPMG, he played a key role in taxation works in relation to Mergers & Acquisitions, IPOs, compliance and corporate finance matters.
Mr Eng is currently a member of the Institute of Certified Public Accountants of Singapore and an accredited Tax Advisor of the Singapore Institute of Accredited Tax Professionals. He was also admitted as a member of the Institute of Chartered Accountants of England and Wales in 1982.
Mr Michael Hwang is an Independent Director and also Chairman of the Nominating Committee. Mr Hwang practices as an independent barrister, international arbitrator and is the Chief Justice of the Dubai International Financial Centre (“DIFC”) Courts.
Mr Hwang was formerly a Judicial Commissioner of the Supreme Court of Singapore and was also one of the first 12 Senior Counsel appointed in Singapore. His previous appointments include Partner and Head of Litigation and Arbitration at Allen & Gledhill, Commissioner of the United Nation Compensation Commission, President of the Law Society of Singapore and non-resident Chief Justice of the DIFC Courts.
Mr Hwang currently also sits on the Boards of various companies such as Singapore Dance Theatre Limited and YTL Starhill Global REIT Management Limited.
Mr Hwang holds an undergraduate and post graduate law degree from Oxford University and an Honorary Doctor of Laws degree from the University of Sydney. He has served as Singapore’s Non-Resident Ambassador to Switzerland and is currently Non-Resident Ambassador to Argentina.